BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 26541420)

  • 1. Androgen receptor CAG repeat length and estrogen receptor status in postmenopausal breast cancer prognosis.
    Cogliati P; Ciniselli CM; Agresti R; Paolini B; Bonini C; Radice P; Krogh V; Verderio P; Venturelli E
    Int J Biol Markers; 2015 Nov; 30(4):e418-24. PubMed ID: 26541420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The polymorphism of CAG repeats in the androgen receptor gene and breast cancer mortality.
    Lee YT; Liu HM; Lee LH; Liu CJ; Lin JS; Chao TC; Tzeng WF; Chiou TJ
    Cancer Biomark; 2015; 15(6):815-22. PubMed ID: 26406407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shorter CAG repeat length in the androgen receptor gene is associated with more aggressive forms of breast cancer.
    Yu H; Bharaj B; Vassilikos EJ; Giai M; Diamandis EP
    Breast Cancer Res Treat; 2000 Jan; 59(2):153-61. PubMed ID: 10817350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher expression of androgen receptor is a significant predictor for better endocrine-responsiveness in estrogen receptor-positive breast cancers.
    Park S; Park HS; Koo JS; Yang WI; Kim SI; Park BW
    Breast Cancer Res Treat; 2012 May; 133(1):311-20. PubMed ID: 22231421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The androgen receptor CAG repeat polymorphism and risk of breast cancer in the Nurses' Health Study.
    Haiman CA; Brown M; Hankinson SE; Spiegelman D; Colditz GA; Willett WC; Kantoff PW; Hunter DJ
    Cancer Res; 2002 Feb; 62(4):1045-9. PubMed ID: 11861380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between androgen receptor gene CAG repeat polymorphism and plasma testosterone levels in postmenopausal women.
    Brum IS; Spritzer PM; Paris F; Maturana MA; Audran F; Sultan C
    J Soc Gynecol Investig; 2005 Feb; 12(2):135-41. PubMed ID: 15695110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alleles with short CAG and GGN repeats in the androgen receptor gene are associated with benign endometrial cancer.
    Rodríguez G; Bilbao C; Ramírez R; Falcón O; León L; Chirino R; Falcón O; Díaz BP; Rivero JF; Perucho M; Díaz-Chico BN; Díaz-Chico JC
    Int J Cancer; 2006 Mar; 118(6):1420-5. PubMed ID: 16187285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen receptor expression and breast cancer survival in postmenopausal women.
    Hu R; Dawood S; Holmes MD; Collins LC; Schnitt SJ; Cole K; Marotti JD; Hankinson SE; Colditz GA; Tamimi RM
    Clin Cancer Res; 2011 Apr; 17(7):1867-74. PubMed ID: 21325075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat.
    Rebbeck TR; Kantoff PW; Krithivas K; Neuhausen S; Blackwood MA; Godwin AK; Daly MB; Narod SA; Garber JE; Lynch HT; Weber BL; Brown M
    Am J Hum Genet; 1999 May; 64(5):1371-7. PubMed ID: 10205268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lin28A and androgen receptor expression in ER-/Her2+ breast cancer.
    Shen H; Yang Y; Zhao L; Yuan J; Niu Y
    Breast Cancer Res Treat; 2016 Feb; 156(1):135-47. PubMed ID: 26944953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined profile of the tandem repeats CAG, TA and CA of the androgen and estrogen receptor genes in breast cancer.
    Anghel A; Raica M; Marian C; Ursoniu S; Mitrasca O
    J Cancer Res Clin Oncol; 2006 Nov; 132(11):727-33. PubMed ID: 16791593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen receptor expression and outcomes in early breast cancer: a systematic review and meta-analysis.
    Vera-Badillo FE; Templeton AJ; de Gouveia P; Diaz-Padilla I; Bedard PL; Al-Mubarak M; Seruga B; Tannock IF; Ocana A; Amir E
    J Natl Cancer Inst; 2014 Jan; 106(1):djt319. PubMed ID: 24273215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shorter CAG repeat length in the AR gene is associated with poor outcome in head and neck cancer.
    Rosa FE; dos Santos RM; Poli-Frederico RC; Canevari Rde A; Nishimoto IN; Magrin J; Rainho CA; Kowalski LP; Rogatto SR
    Arch Oral Biol; 2007 Aug; 52(8):732-9. PubMed ID: 17321486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen receptor gene CAG repeats, estrogen exposure status, and breast cancer susceptibility.
    Wu MH; Chou YC; Yu CP; Yang T; You SL; Chen CJ; Sun CA
    Eur J Cancer Prev; 2008 Aug; 17(4):317-22. PubMed ID: 18562955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphic CAG/CAA repeat length in the AIB1/SRC-3 gene and prostate cancer risk: a population-based case-control study.
    Hsing AW; Chokkalingam AP; Gao YT; Wu G; Wang X; Deng J; Cheng J; Sesterhenn IA; Mostofi FK; Chiang T; Chen YL; Stanczyk FZ; Chang C
    Cancer Epidemiol Biomarkers Prev; 2002 Apr; 11(4):337-41. PubMed ID: 11927493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer.
    Bae SY; Kim S; Lee JH; Lee HC; Lee SK; Kil WH; Kim SW; Lee JE; Nam SJ
    BMC Cancer; 2015 Mar; 15():138. PubMed ID: 25880075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CAG repeat length in exon 1 of the androgen receptor gene is related to age of diagnosis but not germ line BRCA1 mutation status in ovarian cancer.
    Kim SC; Ju W; Mahavni V; Geisler JP; Buller RE
    Int J Gynecol Cancer; 2006; 16 Suppl 1():190-4. PubMed ID: 16515589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long CAG repeat sequence and protein expression of androgen receptor considered as prognostic indicators in male breast carcinoma.
    Song YN; Geng JS; Liu T; Zhong ZB; Liu Y; Xia BS; Ji HF; Li XM; Zhang GQ; Ren YL; Li ZG; Pang D
    PLoS One; 2012; 7(12):e52271. PubMed ID: 23272232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen Receptor Expression and Breast Cancer Survival: Results From the Nurses' Health Studies.
    Kensler KH; Poole EM; Heng YJ; Collins LC; Glass B; Beck AH; Hazra A; Rosner BA; Eliassen AH; Hankinson SE; Winer EP; Brown M; Tamimi RM
    J Natl Cancer Inst; 2019 Jul; 111(7):700-708. PubMed ID: 30445651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CAG polymorphic repeat length in androgen receptor gene combined with pretreatment serum testosterone level as prognostic factor in patients with metastatic prostate cancer.
    Shimbo M; Suzuki H; Kamiya N; Imamoto T; Komiya A; Ueda T; Watanabe M; Shiraishi T; Ichikawa T
    Eur Urol; 2005 Apr; 47(4):557-63. PubMed ID: 15774258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.